All News

    Nurse’s Big Personality Makes Cancer Treatment More Bearable.

    May 6th 2025, 5:00pm

    Article

    She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.

    Givinostat Wins U.S. FDA Fast Track Designation for Patients With PV

    May 6th 2025, 4:00pm

    Article

    Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for patients with polycythemia vera.

    First Patient With Advanced Lung Cancer Dosed With Peluntamig Combo

    May 6th 2025, 3:00pm

    Article

    The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas.

    Delving Into the Braftovi Plus Erbitux FDA Approval for BRAF+ mCRC

    May 6th 2025, 1:00pm

    Article

    Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer with a BRAF V600E mutation.

    A Staunch Advocate For Radiation Oncology Nursing and Compassionate Care

    May 5th 2025, 9:00pm

    Article

    Everyone knows someone who has been affected by cancer.

    A Personalized Approach to Bladder Preservation in Urologic Cancers

    May 5th 2025, 8:00pm

    Video

    Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.

    Mitigating Peripheral Neuropathy During Cancer Treatment

    May 5th 2025, 7:00pm

    Video

    Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenström macroglobulinemia early on and how to treat it.

    My Lung Cancer Journey: With Family, Friends and Medical Professionals

    May 5th 2025, 5:00pm

    Article

    The strongest connections I’ve made are with others who have also been through their own cancer journeys.

    AI Tool Predicts Pediatric Glioma Recurrence With Up to 89% Accuracy

    May 5th 2025, 4:00pm

    Article

    An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods.

    First-Line Keytruda Combo Elicits OS Results in Head and Neck Cancers

    May 5th 2025, 3:00pm

    Article

    First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and neck squamous cell carcinoma.